Hospital readmission after lung transplantation negatively affects quality of life and resource utilization. A secondary analysis of data collected prospectively was conducted to identify the pattern of (incidence, count, cumulative duration), reasons for and predictors of readmission for 201 lung transplant recipients (LTRs) assessed at 2, 6, and 12 mo after discharge. The majority of LTRs (83.6%) were readmitted, and 64.2% had multiple readmissions. The median cumulative readmission duration was 19 days. The main reasons for readmission were other than infection or rejection (55.5%), infection only (25.4%), rejection only (9.9%), and infection and rejection (0.7%). LTRs who required reintubation (odds ratio [OR] 1.92; p = 0.008) or were discharged to care facilities (OR 2.78; p = 0.008) were at higher risk for readmission, with a 95.7% cumulative incidence of readmission at 12 mo. Thirty-day readmission (40.8%) was not significantly predicted by baseline characteristics. Predictors of higher readmission count were lower capacity to engage in self-care (incidence rate ratio [IRR] 0.99; p = 0.03) and discharge to care facilities (IRR 1.45; p = 0.01). Predictors of longer cumulative readmission duration were older age (arithmetic mean ratio [AMR] 1.02; p = 0.009), return to the intensive care unit (AMR 2.00; p = 0.01) and lower capacity to engage in self-care (AMR 0.99; p = 0.03). Identifying LTRs at risk may assist in optimizing predischarge care, discharge planning and long-term follow-up.
Introduction
Hospital readmission is considered an important proxy measure of quality of care and short-term effectiveness of hospital discharge processes (1, 2) . In most cases, readmission has been found to be associated with poorer quality of inpatient care, remediable care deficiencies (3), illness burden and social determinants of health (4) . The Medicare Payment Advisory Commission reported that 75% of readmissions of Medicare beneficiaries were avoidable, resulting in extra cost of $15 billion annually (5, 6) and negatively affecting patients' quality of life. Although the Centers for Medicare and Medicaid Services have begun limiting reimbursement for higher standardized readmission rates for certain medical conditions (e.g. heart failure, acute myocardial infarction and pneumonia) (7, 8) , these penalties are anticipated to be broadened to include other medical and surgical conditions (9) (10) (11) , including transplantation (11) .
Lung transplantation is becoming a more prevalent treatment option for patients with end-stage lung disease (12) (13) (14) . Patients who undergo transplantation are expected to have better physical quality of life (15) and longer life expectancy (16) (17) (18) . Despite advances and improved survival, lung transplant recipients (LTRs) often experience posttransplant complications (19, 20) and unplanned hospital readmissions. Although it is known that the incidence of readmission is highest during the first year after lung transplantation (21, 22) , there is lack of information about how these readmissions unfold over the course of the first year. Furthermore, factors associated with risk of readmission, such as predischarge characteristics (sociodemographic, clinical, self-care), and the reasons for readmission are largely unknown. It is crucial to understand these risk factors to allocate health care resources more efficiently, to reduce readmission rates and to improve LTRs' quality of life (23) . Consequently, the purposes of this study were (i) to describe the pattern of (incidence, count, and cumulative duration) and reasons for readmission during the first year after lung transplantation and (ii) to identify predictors of hospital readmission.
Methods

Design, setting, and sample
The study was a secondary analysis of data from a randomized controlled trial (RCT) to evaluate the efficacy of a mobile health (mHealth) intervention for improving capacity for self-care, self-management and health outcomes during the first year after lung transplantation (24) (ClinicalTrials.gov identifier NCT00818025). The final sample consisted of 201 LTRs who were randomized to one of two groups (intervention or usual care), in view of the fact that the original study did not find a significant impact of the intervention on readmission. Included LTRs in the parent study were aged >18 years, were able to read and speak English, had no history of previous organ or bone marrow transplant, and were able to perform their personal care (24) . All LTRs received a lung transplant between December 2008 and December 2011 at the University of Pittsburgh Medical Center (UPMC) Cardiothoracic Transplantation Program. All LTRs received clinical management according to the standard UPMC protocol for immunosuppression, infection prophylaxis, routine surveillance biopsies, intravenous steroids in case of acute rejection, and follow-up evaluations as needed. For most patients with acute rejection, readmission to the hospital was required because of logistical challenges with home care and comorbidities, particularly diabetes. Some patients, however, were treated with intravenous steroids at an outpatient infusion center or at home. The study was approved by the institutional review board of the University of Pittsburgh.
Data collection and measures
Pattern of readmission: For the purpose of the present study, readmission was defined as a stay in an inpatient hospital setting for at least 24 h following the patient's medical discharge after index transplant hospitalization (22) . Data related to readmission (incidence, count, cumulative duration and reasons for readmission) were collected prospectively during each of the intervals at 0-2, 2-6, and 6-12 mo after discharge. Medical records were used to extract data for patients readmitted to any hospital within the same health care network (UPMC) or from medical records regarding a readmission from outside hospitals (14.8% of total readmissions).
For each interval, readmission incidence was determined based on any readmission, and the count of readmission was the sum of readmissions. The cumulative duration of readmission was the sum of hospital stay days for each interval.
Reasons for readmission: Reasons for readmission were independently classified by two evaluators according to the four categories outlined by the International Society of Heart and Lung Transplantation (21): (i) infection, (ii) rejection, (iii) infection and rejection, or (iv) other than infection or rejection. The category "unable to determine" was used for cases that lacked sufficient data to make a decision. In case of disagreement between the two evaluators, readmission was discussed until consensus was reached for all admissions.
Predictors: Potential predictors of readmission were measured prior to index hospital discharge and included RCT group assignment and sociodemographic, clinical, and self-care characteristics.
Sociodemographic characteristics included sex (male vs. female), age at transplant (years), marital status (married vs. unmarried), race (white vs. nonwhite), education (less than high school vs. high school or higher), and employment (employed vs. unemployed).
Clinical characteristics included underlying lung disease (obstructive vs. nonobstructive), type of transplant procedure (single vs. double), postoperative ventilation period (<48 vs. ≥48 h), return to intensive care unit (ICU; return vs. no return), reintubation (reintubated vs. not reintubated), length of hospital stay (days), and hospital discharge destination (home vs. any care facility).
Self-care characteristics have a crucial role in supporting patients in controlling and reducing the physical and psychological consequences of the disease (25, 26) ; therefore, these characteristics were hypothesized to predict readmission after lung transplantation. The original study used three measures to assess self-care attributes. One measure was perception of self-care agency (PSCA) (27) , a reliable and valid (28) self-report measure of one's capacity for self-care (29) . The PSCA includes 53 Likert-type items scored on a scale of 1-5 and summed for scores that range from 53 to 265, with higher scores indicating greater self-care agency. Internal consistency reliability (Cronbach's a) was 0.94 in the current sample, well above the acceptable level of 0.70 (30) . The second measure was the dyadic adjustment scale (DAS) (31), a reliable self-report measure of the quality of the relationship with the patient's primary lay caregiver. A stronger recipient-caregiver relationship was previously reported to be associated with higher capacity for self-care (32) . The DAS includes 15 Likert-type items scored on a scale of 1-5 and summed for scores that range from 15 to 75, with higher scores indicating higher quality of caregiver relationship (33). Cronbach's a was 0.83 in the current sample. The third measure was the Health Locus of Control internality subscale (34, 35) , a self-report measure of how strongly people believe they are responsible for their own health outcomes (36) . The internality measure is reliable (37) and includes six Likert-type items scored on a scale of 1-6 and summed for scores that range from 6 to 36, with high scores indicating higher internality. Cronbach's a was 0.75 in this sample.
Statistical analysis
Descriptive statistics were used to summarize categorical variables by frequencies and proportions and continuous variables by medians and interquartile ranges (IQRs). Distribution differences of LTRs by readmission status during the first year were compared using the Wilcoxon rank sum test for continuous variables and the chi-square test or its exact counterpart (Fisher exact test) for categorical variables. The extent of missing data was assessed, and only two values were incomplete for the DAS measure; unconditional mean imputation (38) was used to compute scores for these data. The degree of concordance on classification of reasons for readmission between two evaluators was examined by the percentage of agreement before reconciliation and Cohen's j (39).
Regression analysis using generalized estimating equations (GEE) models (40) was used to identify predictors of readmission pattern. GEE allows analysis of repeated measurement of readmission incidence for the three study intervals (0-2, 2-6 and 6-12 mo); this repeated-measures analysis is considered powerful relative to sample size (41) because it allows for studying variability within participants over time (42, 43) . Individual differences in follow-up time during each interval were adjusted using log etransformed of total participation days as offset. To account for attrition over time, the models included the days up to the event (19 deaths, 1 withdrawal) as offset for that time interval and omitted the subsequent intervals from analysis (i.e. censored). Binomial (logistic) and negative binomial distributions were adopted by the GEE regression models for readmission incidence (dichotomous data) and count of readmissions (count data), respectively. Another GEE model used c distribution to assess predictors of readmission duration in case of readmission (44) . For all GEE analyses, univariate regression was first used to identify potential predictors at a significance level of p < 0.10 (45). Retained variables were then entered into a multivariate model to identify the final significant predictors (p < 0.05). Effect sizes in the form of odds ratios (ORs), incidence rate ratios and arithmetic mean ratios were reported with the 95% confidence intervals (CIs) and p-values for the logistic, negative binomial, and c regression models, respectively.
To provide useful information about the likelihood of being readmitted over the course of the first year, competing risk regression analysis was used to calculate and create cumulative incidence plots for the final predictors of readmission incidence identified earlier by the logistic GEE analysis. This method accounts for death as a competing risk for readmission (46, 47) . Time to event was calculated from the date of index discharge until the date of first readmission. In addition, another competing risk regression analysis was conducted to identify the predictors of 30-day readmission, which is broadly used by hospitals, insurers and payers, and regulatory agencies as a measure of hospital quality and as a benchmark for reimbursement (4, 48) .
All statistical testes were two-sided and were conducted using the software packages SPSS (version 22; IBM Corp, Armonk, NY) (49) and Stata (version 14; Stata Corp LP, College Station, TX) (50).
Results
Baseline characteristics of the sample are presented in Table 1 . Only age (p = 0.02) and reintubation status (p = 0.01) were different between the groups of patients who did or did not experience readmission. RCT group assignment was not significantly associated with readmission (p = 0.78).
Reasons for readmission
Of the 568 readmissions during the first year, the evaluators agreed on classification of 94.5% (j = 0.91). Figure 1 presents the percentages of reasons for readmission during each study interval. Reasons categorized as other than infection or rejection (including but not limited to dehydration, nausea, vomiting, diarrhea and acute renal failure) accounted for more than half (55.5%) of readmissions during the first year after discharge; admissions in this category decreased over time (Figure 1 ). The percentages of readmissions categorized as infection The number of lung transplant recipients who were alive at the start of the study. only and rejection only were 25.4% and 9.9%, respectively; admissions in these categories increased with time. Finally, 0.7% of readmissions were categorized as infection and rejection simultaneously and showed little change over time.
Readmission incidence
Of the 201 LTRs, 168 (83.6%) were readmitted to the hospital at least once during the first year. The percentages of readmission incidence are displayed in Table 2 for the study period, which was divided into two intervals of equal duration to facilitate comparison. Results from the logistic regression model examining predictors of readmission incidence are presented in The original first two time intervals (0-2 and 2-6 mo) were combined to create intervals of equal duration. 2 The number of LTRs who were alive and did not withdraw at the start of the time interval. 3 Calculated based on the number of LTRs who were readmitted for each time interval. 1.31-5.87; p = 0.008) were statistically significant risk factors for readmission. Furthermore, 82 (40.8%) of LTRs were readmitted during the first 30 days after lung transplantation discharge. None of the baseline characteristics was identified as a significant predictor of 30-days readmission, and the findings from this analysis were not reported in this paper in the interest of brevity. The percentage of total readmissions each month during the first year after lung transplantation discharge are displayed in Figure 2 , which shows a decline in the number of readmissions over time.
Cumulative incidence of readmission
Results from the competing risks regression model show that the cumulative incidences of readmission, after controlling for reintubation and discharge destination, were 54.5%, 73.7%, and 84.5% at time points 2, 6, and 12 mo, respectively. Figure 3 depicts the cumulative incidences of readmission by the combinations of reintubation and discharge destination during the first year following index discharge. Cumulative incidences of readmission at 12 mo ranged from 80.8% for nonreintubated LTRs discharged home to 95.7% for reintubated LTRs discharged to care facilities.
Readmission count
Slightly less than two-thirds of the sample (64.2%) had multiple readmissions during the first year. The numbers of readmissions for each time interval and for the total study period are displayed in Table 2 . Results from the negative binomial regression indicate that LTRs had fewer readmissions over time (OR 0.92; 95% CI 0.90-0.95; p < 0.001) after adjusting for other predictors in the multivariate model (Table 4) . LTRs who were discharged to care facilities had 1.45 times higher count of readmissions than those who were discharged home (95% CI 1.08-1.94; p = 0.01). Furthermore, for every 1-point increase in capacity for self-care (PSCA score), the count of readmissions would decrease by 1% (95% CI 0.99-1.00, p = 0.03) while holding all other variables in the model constant.
Readmission cumulative duration
Cumulative number of readmission days for the LTRs who were readmitted are presented in Table 2 . The median cumulative duration of all first-year readmissions was 19 days, and more than one-third of LTRs in the sample (37.5%) were readmitted for >30 days. Results from the c regression show that cumulative readmission duration decreased over time (OR 0.91; 95% CI 0.88-0.94; p < 0.001) after controlling for other predictors in the multivariate model (Table 5 ). In addition, for every 1-year increase in age, mean cumulative readmission duration would increase by 2% (95% CI 1.00-1.03; p = 0.009).
For LTRs who returned to the ICU, the mean cumulative readmission duration was twice the mean cumulative readmission duration for LTRs who did not return to the ICU (95% CI 1.17-3.43; p = 0.01) after adjusting for other variables in the model.
Discussion
Little is known about the pattern and predictors of hospital readmissions during the first year following lung transplantation. In this study, we described the incidence, count, cumulative duration and common reasons for readmission and identified certain sociodemographic, clinical and self-care characteristics at the time of transplant as risk factors for readmission within the first year after lung transplantation.
Complications such as gastrointestinal problems (diarrhea (51-53)), nausea and vomiting (54,55)), and renal failure (56-58) are common after lung transplantation and often require hospital readmission. Many of these complications (e.g. nausea) are likely side effects of immunosuppressants and antiviral medications (55) . Such complications decrease with time and with symptomatic treatments (20) , which is consistent with our findings. In contrast, there was an increase in infections as a reason for readmission after 2 mo. This result is likely attributable to changes in the nature of infectious diseases after 2 mo, including the emergence of opportunistic infections (59) and multidrug-resistant bacterial infections (60) due to a combination of prolonged immunosuppression treatment and viral infections (61) .
Reintubation during the index transplant hospitalization was a significant predictor of readmission incidence and was expected, given that reintubation is considered a prognostic factor for lung transplantation survival (62) and an indicator of severe graft dysfunction (63) and is associated with further complications such as nosocomial pneumonia (64) . Novel methods to treat posttransplant respiratory failure and to decrease the need for reintubation, such as rapid extubation and noninvasive positive pressure ventilation (63) , may improve health outcomes and reduce the risk of further complications, leading to lower readmission risk.
We found an association between discharge destination and both readmission incidence and count in the lung transplant population. This result is consistent with findings from other studies reporting that older communitydwelling adults (48, 65) , vascular (66) and colorectal (67) surgery patients, and liver transplant recipients (68) who were discharged to care facilities were at significantly higher risk of readmission than those discharged home. This finding likely reflects the lower functional status of such patients (69) and thus higher risk of readmission. Coordination of care between the transplant center and care facilities such as rehabilitation and other skilled residential settings may improve future health outcomes and reduce risk for frequent readmissions.
Of all self-care characteristics, capacity for self-care was the only factor associated with fewer and shorter hospital readmissions, suggesting the importance of LTRs' active involvement in the self-care process. Perceiving oneself to have greater capacity for self-care was previously found to be associated with actual self-care behaviors and thus improved health outcomes (26) . This study adds to previous reports that found self-care to be associated with fewer hospital readmissions in general (70) (71) (72) (73) . Use of evidence-based protocols for transitional care, effective discharge planning and education about self-care (74) are needed to promote self-care behaviors and to reduce readmission count and duration.
Older age and readmission to the ICU were found to place LTRs at risk for longer readmission duration. Identifying these LTRs at the time of hospital discharge may help modify discharge planning to meet their special needs. For those who require readmission to the hospital, particularly those of older age, mobilization of resources and targeted interventions may help reduce duration of hospital stay.
This study has several limitations. The sample included LTRs from only one transplant center; therefore, the results may not be generalizable. Although the percentage of single-lung transplant procedures in our sample was lower than the respective national average (31%), the sociodemographic characteristics of our sample were generally equivalent to U.S. national lung transplant populations during the same period (75) . In addition, the study is a secondary analysis, so there was limited control over the previously collected variables, and data for some variables of interest were not available, such as characteristics of donors, comorbidities and medication usage, to provide more comprehensive models predicting readmissions. Several risk factors for readmission, such as age and need for reintubation, may not be surprising, given that patients with higher acuity are likely to have worse health outcomes, including readmission profiles. This study, however, is the first to provide empirical evidence of how these factors affect LTR readmission. Furthermore, although several predictors in this study were interdependent and nonmodifiable, they help identify LTRs who are at greater risk of readmission and who may benefit from early supportive interventions. Finally, our data were collected for the first year after discharge, limiting our ability to investigate long-term readmission patterns.
In conclusion, hospital readmission after lung transplantation remains a major complication of the procedure.
In this study, we described and identified the pattern (incidence, count, duration), reasons and predictors of readmission during the first year after lung transplantation. Although the parent study did not find an impact of the mHealth intervention on readmission, the knowledge presented in this study may affect clinical practice, as discussed earlier. Recognition of the risk factors for readmission (i.e. need for reintubation, readmission to the ICU, discharge to an extended care facility, older patient age and report of limited capacity for self-care) at the time of discharge may help mobilize resources to vulnerable subpopulations of patients and enhance the discharge process (76, 77) . Such an endeavor may reduce the cost and effort associated with readmission and guide the use of health care resources (78) .
